Who makes Attenuated HAV Vaccine, H2 Strain?

Attenuated HAV Vaccine, H2 Strain is developed by Institute of Medical Biology, Chinese Academy of Medical Sciences.

What development phase is Attenuated HAV Vaccine, H2 Strain in?

Attenuated HAV Vaccine, H2 Strain is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Attenuated HAV Vaccine, H2 Strain

Institute of Medical Biology, Chinese Academy of Medical Sciences · FDA-approved active Biologic Quality 0/100

At a glance

Generic name	Attenuated HAV Vaccine, H2 Strain
Also known as	Hepatitis A (Live) Vaccine, Freeze-dried
Sponsor	Institute of Medical Biology, Chinese Academy of Medical Sciences
Modality	Biologic
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

The Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines (PHASE4)
Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Attenuated HAV Vaccine, H2 Strain CI brief — competitive landscape report
Attenuated HAV Vaccine, H2 Strain updates RSS · CI watch RSS
Institute of Medical Biology, Chinese Academy of Medical Sciences portfolio CI